From the Research
Deferasirox (Exjade) is typically dosed at 20-30 mg/kg/day orally, once daily, for the treatment of iron overload in patients with transfusional iron overload due to certain rare anemias. The dosing of Deferasirox (Exjade) is crucial in managing iron overload, and the recommended dose is based on the patient's weight and iron levels.
- The dose can be adjusted based on the patient's response to therapy and iron levels, with a maximum dose of 40 mg/kg/day.
- It is essential to monitor the patient's iron levels, liver function, and kidney function during treatment with Deferasirox (Exjade) 1.
- The medication should be taken orally, once daily, and can be taken with or without food.
- Patients should be advised to report any side effects, such as nausea, vomiting, or abdominal pain, to their healthcare provider.
- Regular follow-up appointments are necessary to assess the patient's response to therapy and adjust the dose as needed.
- Deferasirox (Exjade) has been shown to be effective in reducing iron overload and improving quality of life in patients with transfusional iron overload due to certain rare anemias 1.